MM&M’S most-read stories of 2017
Topping the list: The MM&M agency issue, the MM&M Awards winners and shortlist, and how a porn star is providing sex ed to seniors
Topping the list: The MM&M agency issue, the MM&M Awards winners and shortlist, and how a porn star is providing sex ed to seniors
Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner
A shorter list of risks in TV ads helps consumer comprehension; medical-school choice affects prescribing patterns; reps often show docs the same info
If asked, some will equivocate and say they get their facts from medical journals and from published studies, but never from those pesky misleading ads.
The association also recommended that the Centers for Medicare and Medicaid Services negotiate drug prices.
They are asking the American Medical Association to support the policy proposal.
The regulator also took issue with how Orexigen Therapeutics presented the risk information
We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It’s not pretty.
Pharma marketers are producing plenty of exceptional creative work in the DTC realm. There are also plenty that prompt quick checks to make sure that one hasn’t inadvertently clicked over to The Onion.
Mary Skoyles finds that DTC ads are getting better. “There’s a lot of interesting work being done,” she says. “There are more chances being taken.”